Why the FDA rejected a ‘breakthrough’ melanoma drug
May 02, 2026
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals
https://www.scientificamerican.com/article/why-the-fda-rejected-a-breakthrough-melanoma-drug/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service